SCHEMBL14933399

SCHEMBL14933399

O=c1c2ccccc2c2cc(-c3ccccc3)ccc2n1-c1ccc2c(c1)c1ccccc1n2-c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.51
MAPK1 P28482 1/20 0.50
L3MBTL1 Q9Y468 2/20 0.49
KDM4E B2RXH2 2/20 0.49
ATM Q13315 1/20 0.49
MEN1 O00255 3/20 0.42
ALDH1A1 P00352 2/20 0.42
POLB P06746 1/20 0.42
TSHR P16473 1/20 0.42
BRCA1 P38398 1/20 0.42
HSD17B10 Q99714 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
PGR P06401 4/20 0.41
CYP1A2 P05177 1/20 0.41
GLA P06280 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
HPGD P15428 1/20 0.41
CYP2C19 P33261 1/20 0.41
TSPO P30536 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15999725 0.99 KMT2A (0.49) KMT2AMAPK1L3MBTL1KDM4EATM
SCHEMBL15999707 0.97 KMT2A (0.54) KMT2AMAPK1L3MBTL1KDM4EATM
SCHEMBL20632563 0.97 MAPK1 (0.53) KMT2AMAPK1L3MBTL1KDM4EATM
SCHEMBL15999723 0.96 KMT2A (0.50) KMT2AMAPK1L3MBTL1KDM4EATM
SCHEMBL14933457 0.96 MAPK1 (0.54) KMT2AMAPK1L3MBTL1KDM4EATM
SCHEMBL14933337 0.96 KMT2A (0.51) KMT2AMAPK1L3MBTL1KDM4EATM
SCHEMBL16002571 0.96 MAPK1 (0.54) KMT2AMAPK1L3MBTL1KDM4EATM
SCHEMBL14933522 0.96 MAPK1 (0.54) KMT2AMAPK1L3MBTL1KDM4EATM
SCHEMBL14933461 0.96 MAPK1 (0.54) KMT2AMAPK1L3MBTL1KDM4EATM
SCHEMBL14933375 0.96 KMT2A (0.51) KMT2AMAPK1L3MBTL1KDM4EATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3649213-B1 COMPOSITION FOR ORGANIC ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2021-06-23 EP disclosed
US-20200216391-A1 COMPOSITION FOR ORGANIC ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2020-07-09 US disclosed
WO-2019007867-A1 COMPOSITION FOR ORGANIC ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2019-01-10 WO disclosed
US-9337430-B2 Organic electroluminescent device MERCK PATENT GMBH (DE) 2016-05-10 US disclosed
US-9337430-B2 Organic electroluminescent device MERCK PATENT GMBH (DE) 2016-05-10 US disclosed
EP-2773721-B1 ORGANIC ELECTROLUMINESCENT DEVICE MERCK PATENT GMBH (DE) 2015-11-25 EP disclosed
US-20140249308-A1 ORGANIC ELECTROLUMINESCENT DEVICE MERCK PATENT GMBH (DE) 2014-09-04 US disclosed
US-20140249308-A1 ORGANIC ELECTROLUMINESCENT DEVICE MERCK PATENT GMBH (DE) 2014-09-04 US disclosed
WO-2013064206-A1 ORGANIC ELECTROLUMINESCENT DEVICE MERCK PATENT GMBH (DE) 2013-05-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200216391-A1 COMPOSITION FOR ORGANIC ELECTRONIC DEVICES SLCO2B1, SLCO4C1, SLCO2A1 KMT2A 3888/4885MAPK1 4607/4885L3MBTL1 3718/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.